China Still Optimistic About Import And Export Of Pharmaceutical Products Despite Financial Crisis
This article was originally published in PharmAsia News
Executive Summary
China expects its foreign trade of pharmaceutical products to stay robust despite the adverse conditions created by the global financial crisis. China has enjoyed double-digit growth in the import and export of pharmaceutical products in recent years. It is expected that China's competitive advantage in producing active pharmaceutical ingredients will remain strong, especially in exports related to antibiotics, vitamins, painkillers, etc. The export of medical devices is expected to see a steady growth as well. Moreover, the import of key medical devices and technology, and of high-quality, low-cost over-the-counter drugs, will also increase. However, China has to pay close attention to anti-dumping incidents in emerging economies such as Brazil, Russia and India. (Click here for more